{
    "Trade/Device Name(s)": [
        "SuperCheck Pro Blood Glucose Monitoring System",
        "SuperCheck Pro Blood Glucose Meter",
        "SuperCheck Pro Blood Glucose Test Strips",
        "OKmeter Control Solution"
    ],
    "Submitter Information": "OK Biotech Co., Ltd.",
    "510(k) Number": "K213061",
    "Predicate Device Reference 510(k) Number(s)": [
        "K171785"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW"
    ],
    "Summary Letter Date": "July 6, 2022",
    "Summary Letter Received Date": "July 8, 2022",
    "Submission Date": "October 7, 2021",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose Test System"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "SuperCheck Pro Blood Glucose Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Amperometric technology",
        "Enzyme-based detection (GDH-FAD)"
    ],
    "Methodologies": [
        "Quantitative measurement"
    ],
    "Submission Type(s)": [
        "System",
        "Meter",
        "Test Strip",
        "Control Solution"
    ],
    "Document Summary": "FDA 510(k) summary for SuperCheck Pro Blood Glucose Monitoring System for quantitative measurement of glucose in capillary whole blood using amperometric detection.",
    "Indications for Use Summary": "Intended for quantitative measurement of glucose in fresh capillary whole blood from various sites for self-testing by individuals with diabetes mellitus at home as an aid in monitoring diabetes control; not for diagnosis, screening, or neonatal use.",
    "fda_folder": "Clinical Chemistry"
}